2/5
08:45 am
vvos
Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth’s Groundbreaking FDA-Cleared Allergy and Sleep Technologies
Medium
Report
Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth’s Groundbreaking FDA-Cleared Allergy and Sleep Technologies
1/23
05:09 am
vvos
Vivos Therapeutics (NASDAQ:VVOS) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Vivos Therapeutics (NASDAQ:VVOS) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
1/20
05:31 pm
vvos
Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds
Medium
Report
Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds
1/16
08:00 am
vvos
Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds
Medium
Report
Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds
12/16
04:31 pm
vvos
Vivos Therapeutics, Inc. (VVOS) Discusses Strategic Business Model Pivot and Transition in Sleep Apnea Treatment Approach Transcript [Seeking Alpha]
Medium
Report
Vivos Therapeutics, Inc. (VVOS) Discusses Strategic Business Model Pivot and Transition in Sleep Apnea Treatment Approach Transcript [Seeking Alpha]
12/16
08:45 am
vvos
Vivos Therapeutics Announces Grand Opening of Affiliated Sleep Center Near Detroit, Michigan
Low
Report
Vivos Therapeutics Announces Grand Opening of Affiliated Sleep Center Near Detroit, Michigan
12/15
06:21 pm
vvos
Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am EST [Yahoo! Finance]
Low
Report
Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am EST [Yahoo! Finance]
12/15
05:30 pm
vvos
Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am EST
Low
Report
Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am EST
12/3
08:06 am
vvos
Vivos Therapeutics (NASDAQ:VVOS) had its price target lowered by analysts at Ascendiant Capital Markets from $6.50 to $5.50. They now have a "buy" rating on the stock.
Low
Report
Vivos Therapeutics (NASDAQ:VVOS) had its price target lowered by analysts at Ascendiant Capital Markets from $6.50 to $5.50. They now have a "buy" rating on the stock.
12/3
07:57 am
vvos
Vivos Therapeutics (NASDAQ:VVOS) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Low
Report
Vivos Therapeutics (NASDAQ:VVOS) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
11/26
08:10 pm
vvos
Vivos Therapeutics Inc (VVOS) Q3 2025 Earnings Call Highlights: Revenue Surge Amid Strategic ... [Yahoo! Finance]
Low
Report
Vivos Therapeutics Inc (VVOS) Q3 2025 Earnings Call Highlights: Revenue Surge Amid Strategic ... [Yahoo! Finance]
11/19
04:45 pm
vvos
Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025 [Yahoo! Finance]
Medium
Report
Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025 [Yahoo! Finance]
11/19
04:20 pm
vvos
Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025
High
Report
Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025
11/19
08:30 am
vvos
Vivos Therapeutics Schedules Release of Third Quarter 2025 Financial Results and Conference Call
Medium
Report
Vivos Therapeutics Schedules Release of Third Quarter 2025 Financial Results and Conference Call
11/17
08:06 am
vvos
Vivos Therapeutics (NASDAQ:VVOS) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $7.00 price target on the stock.
Low
Report
Vivos Therapeutics (NASDAQ:VVOS) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $7.00 price target on the stock.